Stocks · Healthcare · Medical - Devices
Inogen, Inc. INGN
$5.97 -0.17% Close, Oct 2, 2026 · NASDAQ · Market cap $161.6M
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Over the past year the stock returned -29.1%, behind the S&P 500 by 44.2 percentage points.
- The company holds net cash of $71.5M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 36%
- Revenue growth, 3-year CAGRBottom 19%
- Revenue growth accelerationTop 49%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 45%
- Gross marginBottom 32%
- Operating marginBottom 48%
- Accruals (lower is better)Top 44%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 38%
- Free-cash-flow yieldBottom 47%
- EBITDA / enterprise valueBottom 44%
- Sales / enterprise valueTop 1%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 12%
- 6-month returnBottom 39%
- 1-year return vs S&P 500Bottom 23%
- Distance from 52-week highBottom 47%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 47%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 20%
- Upside to consensus price targetTop 9%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 25%
- Maximum drawdown, 3 yearsTop 36%
- Beta vs S&P 500 (lower is better)Top 47%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 3.4% | 3.2% | ↓ |
| Gross margin | 45.2% | 48.9% | ↑ |
| Operating margin | -9.6% | -8.4% | ↑ |
| FCF margin | -6.5% | -2.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 3.2% | 3.4% | ↓ | Bottom 36% |
| Gross margin | 48.9% | 45.2% | ↑ | Bottom 32% |
| Operating margin | -8.4% | -9.6% | ↑ | Bottom 48% |
| Net margin | -6.9% | -7.6% | ↑ | — |
| Free-cash-flow margin | -2.7% | -6.5% | ↑ | — |
| Return on invested capital | -13.3% | — | Top 45% | |
| Revenue growth, 3-year CAGR | -2.6% | — | Bottom 19% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +16.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 4.23%
- Shareholder yield
- 4.23%
- Share count change, 1 year
- +0.3%
- Share count change, 3-year CAGR
- +5.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +5.1%
- Average 2-day reaction, last 8
- -1.9%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $26.00
- Target vs current price
- +335.5%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 55%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +8.7% | -1.1% | -11.4% | -17.8% | — |
| May 7, 2026 | -25.0% | +1.1% | -4.2% | -11.3% | -5.6% |
| Feb 24, 2026 | +27.8% | +2.8% | +8.8% | +13.6% | +13.6% |
| Nov 5, 2025 | +9.1% | -8.3% | -13.3% | -14.3% | -25.6% |
| Aug 7, 2025 | +31.8% | -6.8% | +22.2% | +28.9% | +29.7% |
| May 7, 2025 | +51.9% | +1.4% | -13.2% | -9.2% | -12.2% |
| Feb 25, 2025 | +26.8% | -3.3% | -17.4% | -25.1% | -36.3% |
| Nov 7, 2024 | +49.0% | -1.1% | +7.9% | -0.2% | +23.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.14 | -$0.15 | +8.7% | $95.1M |
| May 7, 2026 | -$0.30 | -$0.24 | -25.0% | $85.1M |
| Feb 24, 2026 | -$0.26 | -$0.36 | +27.8% | $81.7M |
| Nov 5, 2025 | -$0.20 | -$0.22 | +9.1% | $92.4M |
| Aug 7, 2025 | -$0.15 | -$0.22 | +31.8% | $92.3M |
| May 7, 2025 | -$0.25 | -$0.52 | +51.9% | $82.3M |
| Feb 25, 2025 | -$0.41 | -$0.56 | +26.8% | $80.1M |
| Nov 7, 2024 | -$0.25 | -$0.49 | +49.0% | $88.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 0.25× | — | — | Top 1% |
| Free-cash-flow yield | -5.99% | — | — | Bottom 47% |
| Earnings yield | -15.08% | — | — | Bottom 38% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 2
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.1%
- 200-day average slope (20 days)
- -2.5%
- Distance from 50-day average
- +5.2%
- Distance from 200-day average
- -4.4%
- RSI (14)
- 65.9
- Relative volume
- 1.09×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 42.3%
- Volatility vs own 5-year history
- 10th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.06
- Correlation with S&P 500
- 0.34
- Current drawdown from 1-year high
- -33.3%
- Maximum drawdown, 3 years
- -60.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 4, 2021 | Oct 27, 2023 | -94.9% | 562 days | Not yet recovered |
| Feb 11, 2021 | Mar 4, 2021 | -17.3% | 14 days | 27 days (Apr 13, 2021) |
| May 3, 2021 | Jun 2, 2021 | -14.6% | 21 days | 14 days (Jun 22, 2021) |
| Oct 12, 2020 | Nov 5, 2020 | -13.8% | 18 days | 2 days (Nov 9, 2020) |
| Jan 7, 2021 | Jan 15, 2021 | -10.5% | 6 days | 6 days (Jan 26, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $161.6M
- EPS, diluted (TTM)
- -$0.90
- Revenue (TTM)
- $354.3M
- 52-week range
- $5.05 – $9.13
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $358.0M | $377.2M | $315.7M | $335.7M | $348.7M |
| Gross profit | $176.5M | $153.5M | $126.7M | $154.7M | $165.9M |
| Operating income | $9.2M | -$85.2M | -$109.4M | -$42.5M | -$30.2M |
| Net income | -$6.3M | -$83.8M | -$102.4M | -$35.9M | -$22.7M |
| EPS (diluted) | -$0.28 | -$3.67 | -$4.42 | -$1.52 | -$0.85 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.8M | $80.1M | $82.3M | $92.3M | $92.4M | $81.7M | $85.1M | $95.1M |
| Net income | -$6.0M | -$9.8M | -$6.2M | -$4.2M | -$5.3M | -$7.1M | -$8.3M | -$3.9M |
| EPS (diluted) | -$0.25 | -$0.41 | -$0.25 | -$0.15 | -$0.20 | -$0.26 | -$0.30 | -$0.14 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $23.6M | -$37.5M | -$3.2M | $5.9M | -$11.2M |
| Capital expenditure | -$23.9M | -$21.2M | -$26.5M | -$17.1M | -$10.4M |
| Free cash flow | -$302,000 | -$58.8M | -$29.8M | -$11.2M | -$21.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $15.6M | $1.7M | $1.5M | $811,000 | $28.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $105.5M
- Total assets
- $285.6M
- Total liabilities
- $110.7M
- Total debt
- $15.8M
- Net debt
- -$71.5M
- Shareholders’ equity
- $174.9M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 1,366,129
- Days to cover
- 5.14
- Change vs previous report
- -6.6%
FINRA short interest, settlement date Sep 15, 2026.